secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rafael Holdings, Inc. (RFL)
CIK:        0001713863
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001213900-24-095102
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rafael Holdings reports Q4 net loss $0.19/share; full year loss $1.45/share; merger with Cyclo ongoing
--------------------------------------------------------------------------------

- Q4 net loss from continuing ops $4.5M ($0.19/diluted) vs gain $1.3M ($0.06) year ago.
- Full year net loss $34.4M ($1.45/diluted) vs loss $8.4M ($0.36) prior year; includes $89.9M in-process R&D charge.
- Cash and marketable securities $65.9M as of July 31, 2024.
- Merger with Cyclo Therapeutics (CYTH) progressing; Phase 3 study fully enrolled, interim results mid-2025.
- R&D expenses $4.2M for fiscal year, down from $6.3M due to winding down early-stage programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1713863/000121390024095102/0001213900-24-095102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1713863/000121390024095102/ea0218947-8k_rafael.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-095102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer